AH Bio Fund II, L.P.
SEC CIK 1725721 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| SCTX | Scribe Therapeutics, Inc. | 10% | 697.6K | $5.00M | — | 2 | 2026-07-27 | 2026-07-27 |
Most active insiders at SCTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Aghazadeh Behzad | Dir, 10%, See Remarks | $36.26M | — |
| 2 | GORDON CARL L | Dir | $15.00M | — |
| 3 | ORBIMED ADVISORS LLC | Dir | $15.00M | — |
| 4 | AH Bio Fund II, L.P. | 10% | $5.00M | — |
| 5 | Lucas Svetlana | Chief Business Off | $45.0K | — |
| 6 | Parrot David | CFO | $40.0K | — |
| 7 | Doudna Jennifer A | 10% | — | — |
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DMI | 2026-07-29 19:09 | 2026-07-27 | SCTX | Scribe Therapeutics, Inc. | AH Bio Fund II, L.P. | 10% | C - Cnv Deriv | — | +2.75M | 697.6K | New | — |
| DI | 2026-07-29 19:09 | 2026-07-27 | SCTX | Scribe Therapeutics, Inc. | AH Bio Fund II, L.P. | 10% | P - Purchase | $15.00 | +333.3K | 2.39M | +16% | +$5.00M |
Purchase Sale Sale after option exercise All abbreviations